J Chovancova Selected Research

ethyl 4-isothiocyanatobutanoate

1/2009	Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.
1/2005	Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Chovancova Research Topics

Disease

3	Carcinoma (Carcinomatosis) 01/2009 - 01/2005
1	Hypoxia (Hypoxemia) 01/2007
1	Breast Neoplasms (Breast Cancer) 01/2007

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 01/2009 - 01/2005
2	ethyl 4-isothiocyanatobutanoateIBA 01/2009 - 01/2005
2	isothiocyanic acidIBA 01/2009 - 01/2005
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2007
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2007
1	Carbonic Anhydrase IXIBA 01/2007